Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Register for more free insights and analysis 

You can access a selection of insights and analysis free of charge providing historic, top-level data for the world's leading pharma and biotech companies.

Register here to access a selection of EvaluatePharma free market intelligence content from our EvaluatePharma service including:  

  • Product Sales analysis
  • Pharmaceutical Sales
  • Market Share & Global Ranking
  • Latest comment and analysis from EP Vantage
  • Search 2 years of company news

Search EvaluatePharma free content by Company, Product, Generic name, Therapy Area, Indication and more.  

Bookmark Evaluate News & Insight for free daily news, complimentary reports, tweets and more.

Evaluate Reports 

EP Vantage Not for the Faint of CAR-T: The CAR-T Therapy Landscape in 2015 download EP Vantage's preview of the CAR-T therapy landscape in 2015  

EP Vantage Pharma & Biotech 2015 Preview download EP Vantage's preview of pharmaceutical sector performance in 2015  

EvaluatePharma Orphan Drug Report 2014 new report shows orphan drug market to reach $176 billion by 2020 - download for further insight  

EvaluateMedTech World Preview 2014, Outlook to 2020 download our new report for insights into medical device and diagnostics industry performance to 2020  

EvaluatePharma Budget-busters: The Shift to High-Priced Innovator Drugs in the USA based on an analysis of the Top 100 selling drugs in the USA  

EP Vantage Pharma & Biotech Half-Year Review 2014 reviews the performance of the pharma & biotech industry in the first half of 2014  

EP Vantage EP Vantage MedTech Half-Year Review 2014 provides an overview of the medical device and diagnostic sector's performance in the first half of 2014  

EvaluatePharma World Preview 2014, Outlook to 2020 download the latest edition of our annual report forecasting pharmaceutical industry performance to 2020